SYRE Operating Cash Flow (Statement)
Spyre Therapeutics Inc · Operating Cash Flow (Statement)
SYRE Operating Cash Flow (Statement)
Latest reported-$208.94Mperiod ending
SYRE Cash from Operations (-$7.34M → -$208.94M)
Annual operating cash flow (statement)
High-resolution chart · PNG
SYRE operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -169,252,000 | |
| -157,410,000 | |
| -99,910,000 | |
| -80,144,000 | |
| -53,716,000 | |
| -75,775,000 | |
| -65,692,000 | |
| -32,193,000 | |
| -24,615,000 | |
| -18,840,000 | |
| -10,982,000 | |
| -7,335,000 |